Apollon Wealth Management, LLC Ptc Therapeutics, Inc. Transaction History
Apollon Wealth Management, LLC
- $4.22 Billion
- Q4 2024
A detailed history of Apollon Wealth Management, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 8,839 shares of PTCT stock, worth $497,370. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,839
Previous 17,678
50.0%
Holding current value
$497,370
Previous $655,000
39.24%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding PTCT
# of Institutions
257Shares Held
72.6MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$516 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$437 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$416 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$359 Million4.07% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$185 Million0.24% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $4.03B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...